Associated Papers
Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder.
Nishioka M et al.
Molecular Psychiatry, 2023
37248276 (PubMed )
Supplement: 41380_2023_2096_MOESM2_ESM.xlsx › TableS5
Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder.
Privitera F et al.
Revista Brasileira De Psiquiatria (sao Paulo, Brazil : 1999), 2023
35881528 (PubMed )
Supplement: 1516-4446-rbp-1516444620222650-suppl1.pdf
A rigorous in silico genomic interrogation at 1p13.3 reveals 16 autosomal dominant candidate genes in syndromic neurodevelopmental disorders.
Ben-Mahmoud A et al.
Frontiers in Molecular Neuroscience, 2022
36277487 (PubMed )
Supplement: Table_2.docx
Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder.
Nishioka M et al.
Nature Communications, 2021
34145229 (PubMed )
Supplement: 41467_2021_23453_MOESM4_ESM.xlsx › Supplementary_Data_1
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM5_ESM.xlsx › ANKL9
Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Kataoka M et al.
Molecular Psychiatry, 2016
Select a paper to view details